Back to STATE STREET CORP STATE STREET CORP

DMACDMAC
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in DIAMEDICA THERAPEUTICS INC

STATE STREET CORP holds 646,743 shares of DMAC (DIAMEDICA THERAPEUTICS INC), worth $4.6M as of 2026-Q2. The position was increased (+0.4% shares). DMAC represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$4.6M

Current Shares

646,743

Total Value Change

+$4.4M

Total Shares Change

+580,114

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
646,743
+0.4%
$4.6M0.0%$7.04
27
2026-Q1
Increased
644,211
+2.6%
$4.4M0.0%$7.71
27
2025-Q4
Increased
627,771
+31.7%
$5M0.0%$8.05
34
2025-Q3
Increased
476,583
+89.2%
$3.3M0.0%$6.91
42
2025-Q2
Increased
251,948
+196.3%
$982,5970.0%$3.84
27
2025-Q1
Unchanged
85,029
0.0%
$322,2600.0%$3.82
0
2024-Q4
Increased
85,029
+23.7%
$461,7070.0%$5.34
20
2024-Q3
Unchanged
68,729
0.0%
$287,9750.0%$4.18
0
2024-Q2
Increased
68,729
+3.1%
$202,7510.0%$2.95
16
2024-Q1
Unchanged
66,629
0.0%
$184,5620.0%$2.77
0
2023-Q4
New
66,629
-
$189,2260.0%$2.84
35

Other major holders of DMAC: COOPERMAN LEON G, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used